Vanguard Group
BOLD

Vanguard Group’s Boundless Bio BOLD Stock Holding History

Vanguard Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$795K Buy
662,757
+93,100
+16% +$116K ﹤0.01% 3834
2025
Q3 		$701K Buy
569,657
+88,390
+18% +$102K ﹤0.01% 3874
2025
Q2 		$486K Sell
481,267
-105,173
-18% -$140K ﹤0.01% 3924
2025
Q1 		$886K Buy
586,440
+252,575
+76% +$524K ﹤0.01% 3747
2024
Q4 		$968K Buy
333,865
+69,654
+26% +$203K ﹤0.01% 3778
2024
Q3 		$917K Buy
264,211
+170,488
+182% +$618K ﹤0.01% 3801
2024
Q2 		$363K Buy
93,723
+33,723
+56% +$322K ﹤0.01% 4072
2024
Q1 		$855K Buy
+60,000
New +$855K ﹤0.01% 3863

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Vanguard Group's BOLD Position: Q4 2025 in Review

Vanguard Group increased its Boundless Bio (BOLD) stake by 16% in Q4 2025, buying an estimated $116K and bringing the position to 662,757 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #3834.

Vanguard Group first reported a position in BOLD in Q1 2024 and has held it in 8 quarters since. The position peaked at $968K in Q4 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q4 2025.

  • Vanguard Group held 662,757 shares of Boundless Bio worth $795K as of Q4 2025.
  • Vanguard Group bought 93,100 Boundless Bio shares in Q4 2025, an estimated $116K.
  • Boundless Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3834 holding.
  • Vanguard Group first reported a position in Boundless Bio in Q1 2024 and has held it in 8 quarters since.
  • Vanguard Group's Boundless Bio position peaked at $968K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.